A landmark $6.7bn deal for NewMed Energy and Ratio Energies to supply Dalia Energies with gas from the Leviathan gas field risks turning litigious. The two companies, which have 45.34% and 15% stakes respectively in Leviathan, notified Dalia on 24 September that they were terminating the deal, but Dalia disputes this and Israel’s Competition Authority approved most of the deal on 6 October.
The two sellers maintain that the deal has been scrapped, arguing that the required conditions were not met by the contractual (undisclosed) deadline. (CONTINUED – 617 WORDS)
Read this article for free
Gain access to over 60-years of energy analysis and news
Delve into the details backed by data
Exclusive information from high-level officials
Assess future risks and opportunities